Mr. Koppikar has been a member of our board since October 2026, bringing a distinguished track record of financial leadership across multiple stages of company growth in the biopharmaceutical industry. He has served as Chief Financial Officer of Verily Health Inc., a healthcare data intelligence company focused on enabling more personal, predictive, and precise health solutions, since April 2023. At Verily, Mr. Koppikar is responsible for the finance, real estate and workplace services, and corporate development functions. Previously, Mr. Koppikar served as Executive Vice President and Chief Financial Officer at Atara Biotherapeutics from 2018 to 2023, where he oversaw the finance, information technology, and investor relations functions. Prior to Atara, Mr. Koppikar held several senior financial leadership positions at Gilead Sciences from 2011 to 2018 and at Amgen from 2001 to 2011. He began his career at Honeywell Aerospace (formerly AlliedSignal). Mr. Koppikar currently serves on the Board of Directors of C4 Therapeutics, Inc. (Nasdaq: CCCC). He holds a Bachelor of Science degree in Aerospace Engineering from the University of Maryland, a Master of Science degree in aeronautical and astronautical engineering from Stanford University, and a Master of Business Administration degree in finance and marketing from The Anderson School at University of California Los Angeles.
Insmed
Your Privacy Choices